A randomized, double blind, parallel assignment, placebo-controlled, two arm study to evaluate the safety and efficacy of iGlow (poly herbal preparation) on overall skin health among healthy adult volunteers

IndusViva HealthSciences Pvt Ltd0 个研究点目标入组 90 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1.Subjects in generally good health
•2.Subjects age group 18 - 55 years
•3.Subjects willing to follow the suggested diet plan.
•4.Subjects willing to give a written informed consent and come for a regular follow up
•5.Subject willing to abide by and comply with the study protocol
•6.Subject has not participated in a similar investigation in the past four weeks.
•7.Subjects having visible fine lines and wrinkles in periorbital area (CrowÃ¢â?¬•s feet), nasolabial areas, forehead , and perioral regions of the face
•8.Subjects having mild to moderate naso-labial folds
•9.Subjects having apparent mild to moderate crowÃ¢â?¬•s feet in unanimated face
•10.Subjects who have not under gone any facial anti-ageing
•procedures (e.g.Botulinum dermal filler injections, laser resurfacing) in the past 3 months.
•11.Subject should be willing to abstain from spa treatments/facials during the study period

•1.A known history or present condition of allergic response to any cosmetic products.
•2.Subjects having severe photo-aging.
•3.Subject having skin diseases (e.g. moderate to severe acne vulgaris face or nodulocystic acne, psoriasis, active atopic dermatitis, melasma, lichen planus pigmentosus/ Achy dermatosis, pigmented contact dermatitis or other cutaneous manifestations), which will interfere with the test readings.
•4.Subjects on oral medications (e.g. steroids, anti-oxidant) or any skin supplement for skin care which will compromise the study.
•5.Systemic treatment which may modify the cutaneous state on the day of inclusion or in the previous 30 days, including retinoid therapy.
•6.Subjects not willing to discontinue other topical anti-ageing, anti- wrinkle facial products.
•7.Subjects who are pregnant, lactating or nursing.
•8.Hypersensitivity to any component of the tested products.
•9.History of intense sun exposure.
•10.Chronic illness which may influence the cutaneous state.
•11.Subject participating in any other cosmetic or therapeutic trial.
•12.Any underlying uncontrolled medical illness including diabetes mellitus, hypertension, liver disease or history of alcoholism, HIV, hepatitis, or any other serious medical illness

发起方

IndusViva HealthSciences Pvt Ltd